Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Christopher Scally Image

      Christopher Scally, M.D., M.S.

      Department of Surgical Oncology, Division of Surgery

      About Dr. Christopher Scally

      Christopher Scally, M.D., M.S., is an Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. His clinical practice focuses on the care of patients with advanced soft-tissue sarcomas. Dr. Scally has particular interest in minimally invasive surgical approaches when appropriate, particularly in the treatment of Gastrointestinal Stromal Tumors (GIST).



      Dr. Scally received his undergraduate degree from the University of Notre Dame and his medical degree from Vanderbilt University School of Medicine. He completed his General Surgery training at the University of Michigan, followed by a fellowship in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center. He also holds a Masters Degree in Healthcare Research from the University of Michigan, where he was a fellow in the Center for Healthcare Outcomes and Policy.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Assistant Professor, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Clinical Interests

      Dr. Scally cares for patients with soft tissue sarcomas both in the abdomen/retroperitoneum as well as truncal and extremity sarcomas. Dr. Scally has particular interest in minimally invasive surgical approaches when appropriate, particularly in the treatment of Gastrointestinal Stromal Tumors (GIST).

      Education & Training

      Degree-Granting Education

      2015University of Michigan Rackham School of Graduate Studies, Ann Arbor, Michigan, US, Healthcare Research, MS
      2010Vanderbilt University School of Medicine, Nashville, Tennessee, US, MD
      2005University of Notre Dame, Notre Dame, Indiana, US, Psychology, BA

      Postgraduate Training

      2017-2019Clinical Fellowship, Complex General Surgical Oncology, MD Anderson Cancer Center, Houston, Texas
      2013-2015T32 Research Fellowship, Center for Healthcare Outcomes & Policy, University of Michigan, Ann Arbor, Michigan
      2010-2017Clinical Residency, General Surgery, University of Michigan, Ann Arbor, Michigan

      Licenses & Certifications

      2020Complex General Surgical Oncology
      2017American Board of Surgery
      2017Texas Medical License
      nullMississippi State Board of Medical Licensure
      nullAlabama Board of Medical Examiners
      nullGeorgia Composite Medical Board
      nullLouisiana State Board of Medical Examiners
      nullOklahoma State Board of Medical Licensure
      nullTennessee Board of Medical Examiners
      nullWashington State Department of Health
      nullArizona Board of Medical Examiners
      nullFlorida Board of Medicine

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2026

      Administrative Appointments/Responsibilities

      Associate Program Director, Complex General Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Wellness Officer, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2025

      Program Director, International Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - 2024

      General Surgery Residency Program Director, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Other Professional Positions

      Consultant, Web Developer, McGraw Hill Professional, Ann Arbor, Michigan, 2011 - 2013

      Extramural Institutional Committee Activities

      Member, Sarcoma Center Safety Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Sarcoma and Orthopedics Center Steering Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Chair, Sarcoma Surgical Care Conference, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Division of Surgery Program Directors Educational Working Group, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Chair, Complex General Surgical Oncology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Co-Chair, Sarcoma Surgical Care Conference, The University of Texas MD Anderson Cancer Center, 2022 - 2024

      Moderator, Sarcoma Multidisciplinary Conference, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Alternate member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Physician representative, Commission on Cancer Advisory Group, The University of Texas MD Anderson Cancer Center, 2020 - 2024

      Member, Sarcoma Physician Efficiency Sprint Physician Champion, The University of Texas MD Anderson Cancer Center, 2019 - 2020

      Member, Complex General Surgical Oncology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Member, Complex General Surgical Oncology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Member, Medical Records Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2023

      Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2021

      Member, Graduate Medical Education Wellness & Career Sustainability Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2019

      Editorial Activities

      Editorial Board Member, Surgical Council on Resident Education (SCORE), 2022 - Present

      Honors & Awards

      2025 - 2026American Society of Clinical Oncology (ASCO) Leadership Development Program: Education Scholars class
      2024UT Health Educators Fellowship Program, University of Texas
      2022Michael Zinner Health Services Research Fellowship Program Award, Surgical Outcomes Club
      2021Fiscal Year 2021: Top 1% Providers, The University of Texas, MD Anderson Cancer Center
      2020Advanced Cancer Therapies 2020 SSO/ACPMP Travel Award, Society of Surgical Oncology & Appendix Cancer Pseudomyxoma Peritonei Research Foundation
      2016 - 2017Administrative Chief Resident, University of Michigan Department of Surgery
      2016Outstanding Physician Communication Award, University of Michigan Department of Surgery
      2015Clinical Congress Quality, Safety and Outcomes Research Award, American College of Surgeons
      2014New Resident Member Research Award, Association for Academic Surgery
      2013Research Fellow Award, Frederick A. Coller Surgical Society
      2010Making a Difference Award, University of Michigan
      2008Outstanding Volunteer of the Year Award, Shade Tree Family Clinic, Vanderbilt University
      2005Cum Laude, University of Notre Dame
      2001 - 2005Glynn Family Honors Program, University of Notre Dame
      2001 - 2005Dean's List, University of Notre Dame

      Professional Memberships

      Association for Academic Surgery

      2020 - Present

      Western Surgical Association

      2019 - Present

      Society for Surgery of the Alimentary Tract

      2019 - 2024

      Frederick A. Coller Surgical Society

      2017 - Present

      American Society of Clinical Oncology

      2015 - Present

      Association for Surgical Education

      2014 - Present

      Society of Surgical Oncology

      2014 - Present

      Surgical Outcomes Club

      2013 - Present

      American College of Surgeons (ACS)

      2013 - Present

      Association of Program Directors in Surgery

      2011 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2024. Gastrointestinal Stromal Tumors: CGSO Board Preparation. Invited. CGSO Fellows Conference. Houston, Texas, US.
      2. 2023. Core Principles of Surgical Palliative Care. Invited. CGSO Fellows Conference. Houston, Texas, US.
      3. 2023. Management of Inpatient Acute Surgical Oncology Consults. Invited. CGSO Fellows Conference. Houston, Texas, US.
      4. 2022. Core Principles of Surgical Palliative Care. Invited. CGSO Fellows Conference. Houston, Texas, US.
      5. 2022. Management of Inpatient Acute Surgical Oncology Consults. Invited. CGSO Fellows Conference. Houston, Texas, US.
      6. 2022. Cytoreductive Surgery and HIPEC for Colorectal Cancer: Review of the Evidence Base. Invited. CGSO Fellows Conference. Houston, Texas, US.
      7. 2021. Soft Tissue Sarcoma. Invited. Disease Site Educational Series, Core Research Staff. Houston, Texas, US.
      8. 2021. Management of Inpatient Acute Surgical Oncology Consults. Invited. CGSO Fellows Conference. Houston, Texas, US.
      9. 2021. Core Principles of Surgical Palliative Care. Invited. CGSO Fellows Conference. Houston, Texas, US.
      10. 2021. Cytoreductive Surgery and HIPEC for Colorectal Cancer: Review of the Evidence Base. Invited. CGSO Fellows Conference,. Houston, Texas, US.
      11. 2020. 6.Management of Peritoneal Surface Malignancies: CGSO Board Preparation. Invited. CGSO Fellows Conference. Houston, Texas, US.
      12. 2020. Management of Inpatient Acute Surgical Oncology Consults. Invited. CGSO Fellows Conference. Houston, Texas, US.
      13. 2020. 5.Core Principles of Surgical Palliative Care. Invited. CGSO Fellows Conference. Houston, Texas, US.
      14. 2020. Things we do for no reason: Surgical Dogma vs Current Evidence. Invited. Surgical Physician Assistants Continuing Education Series. Houston, Texas, US.
      15. 2019. HIPEC: Past, Present, and Future. Invited. Grand Rounds. Houston, Texas, US.
      16. 2019. Management of Peritoneal Surface Malignancies: CGSO Board Preparation. Invited. CGSO Fellows Conference. Houston, Texas, US.
      17. 2018. Systemic Therapies and Preoperative Decision Making in Sarcoma Surgery. Invited. CGSO Fellows Conference. Houston, Texas, US.
      18. 2017. The History of Graduate Medical Education Funding. Invited. Grand Rounds, US.

      Regional Presentations

      1. 2018. An Unusual Cause of Abdominal Pain: Clinical Vignette. Conference. An Unusual Cause of Abdominal Pain: Clinical Vignette, US.
      2. 2015. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees. Conference. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees, US.
      3. 2015. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients. Conference. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients, US.

      National Presentations

      1. 2026. Prospective evaluation of safety and patient satisfaction with apixaban versus low molecular weight heparin for extended prophylaxis after cancer surgery. Conference. Prospective evaluation of safety and patient satisfaction with apixaban versus low molecular weight heparin for extended prophylaxis after cancer surgery, US.
      2. 2024. Workup and Management of Soft Tissue Sarcoma. Invited. National Collaborative Didactics, US.
      3. 2023. Workup and Management of Appendiceal Neoplasms. Invited. National Collaborative Didactics, US.
      4. 2021. Panelist/Surgical management of abdominal pain in the setting of neutropenia. Conference. ACS CRP Educational Series - Surgical Emergencies in Advanced Patients, US.
      5. 2021. Workup of Soft Tissue Neoplasm. Invited. SCORE School Seminar Series, US.
      6. 2020. Low-Grade Appendiceal Mucinous Neoplasms: Treatment Variation and Long-Term Outcomes. Conference. Low-Grade Appendiceal Mucinous Neoplasms: Treatment Variation and Long-Term Outcomes, US.
      7. 2019. Prognostic Significance of Acellular Mucin in Patients undergoing Cytoreductive Surgery and HIPEC (CRS/HIPEC) for Appendiceal Neoplasm. Conference. Prognostic Significance of Acellular Mucin in Patients undergoing Cytoreductive Surgery and HIPEC (CRS/HIPEC) for Appendiceal Neoplasm, US.
      8. 2018. The Evolving Application of Panel-Based Tests for Defining Hereditary Colorectal Cancer Susceptibility. Conference. The Evolving Application of Panel-Based Tests for Defining Hereditary Colorectal Cancer Susceptibility, US.
      9. 2015. Video Ratings of Surgical Skill and Late Outcomes Following Bariatric Surgery. Conference. Video Ratings of Surgical Skill and Late Outcomes Following Bariatric Surgery, US.
      10. 2015. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees. Conference. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees, US.
      11. 2015. Resident-Attending Interactions and Progressive Autonomy in the Operating Room. Conference. Resident-Attending Interactions and Progressive Autonomy in the Operating Room, US.
      12. 2015. Comparing Perioperative Processes of Care in High and Low Mortality Centers Performing Pancreatic Surgery. Conference. Comparing Perioperative Processes of Care in High and Low Mortality Centers Performing Pancreatic Surgery, US.
      13. 2015. Incorporating Transition to Practice into a HPB Fellowship: A model for Graduated Autonomy. Conference. Incorporating Transition to Practice into a HPB Fellowship: A model for Graduated Autonomy, US.
      14. 2015. National Trends in Resection of Cystic Lesions of the Pancreas. Conference. National Trends in Resection of Cystic Lesions of the Pancreas, US.
      15. 2015. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients. Conference. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients, US.
      16. 2015. Hospital Competition and Adoption of New Procedures in Low Volume Settings. Conference. Hospital Competition and Adoption of New Procedures in Low Volume Settings, US.
      17. 2014. Impact of Surgical Quality Improvement on Payments in Medicare Patients. Conference. Impact of Surgical Quality Improvement on Payments in Medicare Patients, US.

      Formal Peers

      1. 2021. Soft Tissue Neoplasm, Part 2 of 2. Invited. Webinar, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2022 - 2024
      Title:The Impact of Sleep Disturbance on Patients Undergoing Cancer Surgery
      Funding Source:U.T. MD Anderson
      Role:PI
      ID:2022-00061477-Y1
      Date: 2013 - 2015
      Title:T32 Institutional Training Grant
      Funding Source:NIH/NCI
      Role:Research Trainee
      ID:5T32CA009672-23
      Date: 2013 - 2015
      Title:Frederick A. Coller Surgical Society Research Fellowship Grant
      Funding Source:Frederick A. Coller Surgical Society
      Role:Fellowship

      Selected Publications

      Peer-Reviewed Articles

      1. Landry JP, Bhalla AD, Landers SM, Lazcano R, Parker LA, Miller TM, Niemi N, Lyu H, Lillemoe H, Keung EZ, Scally CP, Roland CL, Hunt KK, Slopis JM, McCutcheon IE, Boudreau B, Wilson-Robles H, Lazar AJ, Rai K, Wiener DJ, Davis BW, Wustefeld-Janssens B, Torres KE. Cross-species Study of Canine and Human Peripheral Nerve Sheath Tumors: Clinical and Molecular Perspectives. bioRxiv, 2026. e-Pub 2026. PMID: 42619932.
      2. Malik, N, Traweek, R, Lyu, H, Witt, RG, Chiang, YJ, Cass, SH, Cope, B, Mericli, AF, Lillemoe, HA, Scally, CP, Torres, KE, Hunt, KK, Roland, CL, Keung, EZ. Timing and Frequency of Surveillance After Resection of Extremity and Trunk Soft Tissue Sarcoma. Annals of surgical oncology 33(7):6859-6866, 2026. e-Pub 2026. PMID: 41807838.
      3. Malik, N, Traweek, R, Lyu, H, Witt, RG, Chiang, YJ, Cass, SH, Cope, B, Mericli, AF, Lillemoe, HA, Scally, CP, Torres, KE, Hunt, KK, Roland, CL, Keung, EZ. ASO Visual Abstract. Annals of surgical oncology 33(7):6919-6920, 2026. e-Pub 2026. PMID: 41913009.
      4. Pattalachinti VK, Seldomridge A, Yousef A, Yousef M, Fallon EA, McCullough J, Gunes BB, Song Y, Scally CP, Mansfield P, White MG, Fournier KF, Helmink BA, Shen JP. Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels. JAMA Netw Open 9(5):e2610569, 2026. e-Pub 2026. PMID: 42081241.
      5. Arifin, AJ, Bishop, AJ, Mitra, D, Yoder, A, Araujo, DM, Haddad, EF, Ratan, R, Livingston, JA, Lewis, VO, Lin, PP, Moon, BS, Keung, EZ, Roland, CL, Scally, CP, Mericli, AF, Guadagnolo, BA, Farooqi, AS. Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma. Practical radiation oncology 16(2):169-175, 2026. e-Pub 2026. PMID: 41579133.
      6. Seldomridge, AN, White, MG, Scally, CP, Royal, RE, Routbort, MJ, Iorgulescu, J, Overman, MJ, Lee, SM, Foo, WC, Taggart, MW, Song, Y, Mansfield, PF, Fournier, KF, Shen, JY, Helmink, BA. Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms. Annals of surgical oncology 33(3):2376-2387, 2026. e-Pub 2026. PMID: 41225239.
      7. Yoder, A, Netherton, T, Wang, X, Lim, TY, Wang, C, Luo, D, Wang, C, Thrower, SL, Nguyen, C, Lyu, H, Scally, CP, Roland, CL, Mitra, D, Bishop, AJ, Farooqi, AS, Guadagnolo, BA. The Impact of Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities When Treating Abdominopelvic Soft-Tissue Sarcomas With Preoperative Radiation Therapy. Advances in Radiation Oncology 11(2), 2026. e-Pub 2026. PMID: 41492444.
      8. Malik, N, Kim, S, Scally, CP, Keung, EZ, Lillemoe, HA, Torres, KE, Hunt, KK, Khan, S, Roland, CL, Lyu, H. The Impact of Vascular Management on Postoperative Complications in Patients Undergoing Surgery for Retroperitoneal Leiomyosarcoma. Current Oncology 33(2), 2026. e-Pub 2026. PMID: 41744854.
      9. Dineen, SP, Berman, R, Blazer, D, Fahy, BN, Grignol, V, Foshag, LJ, Lai, L, Ongchin, MC, Reddy, S, Saied, A, Scally, CP, Russell, MC. In-Person and Virtual Interviews for Complex General Surgical Oncology Fellowship. Annals of surgical oncology 33(1):346-352, 2026. e-Pub 2026. PMID: 40928577.
      10. Traweek RS, Zoghbi M, Lazcano R, Cope BM, Bishop AJ, Farooqi A, Mitra D, Yoder AK, Guadagnolo BA, Ingram DR, Wani K, Shamsutdinova D, Lazar AJ, Wang WL, Scally CP, Keung EZ, Torres KE, Hunt KK, Ratan R, Livingston JA, Nakazawa MS, Araujo DM, Patel S, Ravi V, Conley AP, Zarzour MA, Somaiah N, Roland CL, Nassif Haddad EF. Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. ESMO Open 10(7):105493, 2025. e-Pub 2025. PMID: 40561658.
      11. Marincola Smith, P, Seldomridge, AN, Chiang, YJ, White, MG, Song, Y, Scally, CP, Mansfield, PF, Fournier, KF, Helmink, BA. Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burden. Surgical Oncology Insight 2(2), 2025. e-Pub 2025. PMID: 40740309.
      12. White, MG, Ayabe, RI, Zeineddine, MA, Zeineddine, F, Yousef, A, Yousef, M, Galbraith, NJ, Iorgulescu, JB, Scally, CP, Fournier, KF, Newhook, TE, You, YN, Willis, JA, Kopetz, S, Chang, GJ, Shen, JY, Uppal, A. Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis. Translational Oncology 55, 2025. e-Pub 2025. PMID: 40184716.
      13. Fallon, EA, Awiwi, M, Bhutiani, N, Helmink, BA, Scally, CP, Mansfield, PF, Fournier, KF, Vikram, R, Uppal, A, White, MG. Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis. Annals of surgical oncology 32(4):2923-2931, 2025. e-Pub 2025. PMID: 39730964.
      14. Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, A, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
      15. Torres MB, Leung CH, Zoghbi M, Lazcano R, Ingram D, Wani K, Keung EZ, Zarzour MA, Scally CP, Hunt KK, Conley A, Bishop AJ, Guadagnolo BA, Farooqi A, Mitra D, Yoder AK, Nakazawa MS, Araujo D, Livingston A, Ratan R, Patel S, Ravi V, Lazar AJ, Roland CL, Somaiah N, Nassif Haddad EF. Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience. Front Immunol 16:1567736, 2025. e-Pub 2025. PMID: 40370451.
      16. Bishop, AJ, Mitra, D, Farooqi, AS, Swanson, DM, Hempel, C, Willis, T, Pearlnath, C, Wang, W, Ratan, R, Somaiah, N, Benjamin, RS, Torres, KE, Hunt, KK, Scally, CP, Keung, EZ, Satcher, R, Bird, JE, Lin, PP, Moon, BS, Lewis, VO, Roland, CL, Guadagnolo, BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS). Cancer 131(1), 2025. e-Pub 2025. PMID: 39192597.
      17. Lyu, H, Witt, RG, Rajkot, N, Keung, EZ, Torres, KE, Hunt, KK, Somaiah, N, Lazar, A, Roland, CL, Scally, CP. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Annals of surgical oncology 31(13):9258-9264, 2024. e-Pub 2024. PMID: 39230849.
      18. Gingrich, AA, Wangsiricharoen, S, Torres, MB, Ravi, V, Ratan, R, Keung, EZ, Scally, CP, Lazar, A, Wang, W, Roland, CL, Hunt, KK, Yu, W, Torres, KE. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas). Annals of surgical oncology 31(12):7950-7956, 2024. e-Pub 2024. PMID: 39150618.
      19. Traweek RS, Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Ann Surg Oncol 31(6):4138-4147, 2024. e-Pub 2024. PMID: 38396039.
      20. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
      21. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2024. PMID: 37914142.
      22. Yousef A, Yousef M, Zeineddine MA, More A, Fanaeian M, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine FA, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally CP, Kee B, Kopetz S, Goldstein D, Strach M, Williamson A, Aziz O, Barriuso J, Uppal A, White MG, Helmink B, Fournier KF, Raghav KP, Taggart MW, Overman MJ, Shen JP. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open 7(2):e240260, 2024. e-Pub 2024. PMID: 38416491.
      23. Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KF. Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol 31(1):614-621, 2024. e-Pub 2024. PMID: 37872456.
      24. White MG, Bhutiani N, Helmink BA, Taggart M, Foo WC, Mansfield PF, Fournier KF, Scally CP. Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol 30(13):8138-8143, 2023. e-Pub 2023. PMID: 37702905.
      25. Erstad DJ, Robinson KA, Beaty K, Rafeeq S, Chiang YJ, Raghav K, Shen JP, Overman MJ, Foo WC, Taggart MW, Mansfield PF, Royal RE, Fournier KF, Scally CP. Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. Langenbecks Arch Surg 408(1):110, 2023. e-Pub 2023. PMID: 36853519.
      26. Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB. Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Ann Surg Oncol 30(12):7840-7847, 2023. e-Pub 2023. PMID: 37620532.
      27. Bhutiani N, White MG, Kim BJ, Scally CP, Helmink BA, Mansfield PF, Fournier KF, Royal RE. Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols. Ann Surg Oncol 30(12):6981-6982, 2023. e-Pub 2023. PMID: 37624514.
      28. Yousef A, Yousef M, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally C, Kee B, Kopetz S, Goldstein D, Uppal A, White MG, Helmink B, Fournier K, Raghav K, Taggart M, Overman MJ, Shen JP. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma. medRxiv, 2023. e-Pub 2023. PMID: 37745596.
      29. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol 30(6):3668-3676, 2023. e-Pub 2023. PMID: 36723723.
      30. Shen JP, Yousef AM, Zeineddine FA, Zeineddine MA, Tidwell RS, Beaty KA, Scofield LC, Rafeeq S, Hornstein N, Lano E, Eng C, Matamoros A, Foo WC, Uppal A, Scally C, Mansfield P, Taggart M, Raghav KP, Overman MJ, Fournier K. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. JAMA Netw Open 6(6):e2316161, 2023. e-Pub 2023. PMID: 37261831.
      31. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):926-940, 2023. e-Pub 2023. PMID: 36115928.
      32. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):480-489, 2023. e-Pub 2023. PMID: 36085392.
      33. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
      34. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
      35. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol, 2022. e-Pub 2022. PMID: 35501583.
      36. Hirata Y, Scally C, Badgwell BD, Ikoma N. Robotic excision of gastric and duodenal gastrointestinal stromal tumor. Updates Surg 74(4):1483-1484, 2022. e-Pub 2022. PMID: 35247206.
      37. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
      38. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract 18(7):OP2100819, 2022. e-Pub 2022. PMID: 35263166.
      39. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-World Use of Palbociclib Monotherapy in Retroperitoneal Liposarcomas at a Large Volume Sarcoma Center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
      40. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. e-Pub 2022. PMID: 35224688.
      41. Raghav K, Liu S, Overman MJ, Willett AF, Knafl M, Fu SC, Malpica A, Prasad S, Royal RE, Scally CP, Mansfield PF, Wistuba II, Futreal AP, Maru DM, Solis Soto LM, Parra Cuentas ER, Chen H, Villalobos P, Verma A, Mahvash A, Hwu P, Cortazar P, McKenna E, Yun C, Dervin S, Schulze K, Darbonne WC, Morani AC, Kopetz S, Fournier KF, Woodman SE, Yao JC, Varadhachary GR, Halperin DM. Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov 11(11):2738-2747, 2021. e-Pub 2021. PMID: 34261675.
      42. Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
      43. Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open 4(3):e210945, 2021. e-Pub 2021. PMID: 33734413.
      44. Scally CP, Fournier KF, Mansfield PF. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. JAMA Surg 156(3):e206364, 2021. e-Pub 2021. PMID: 33502464.
      45. Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CL. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol 28(1):570-575, 2021. e-Pub 2021. PMID: 32409969.
      46. Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
      47. Raghav K, Shen JP, Jácome AA, Guerra JL, Scally CP, Taggart MW, Foo WC, Matamoros A, Shaw KR, Fournier K, Overman MJ, Eng C. Integrated clinicomolecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br J Cancer. e-Pub 2020. PMID: 32733093.
      48. Scally CP, Robinson K, Blumenthaler AN, Bruera E, Badgwell BD. Identifying Core Principles of Palliative Care Consultation in Surgical Patients and Potential Knowledge Gaps for Surgeons. J Am Coll Surg 231(1):179-185, 2020. e-Pub 2020. PMID: 32311465.
      49. Lillemoe HA, Scally CP, Adams CL, Bednarski BK, Balch CM, Aloia TA, Gershenwald JE, Lee JE, Grubbs EG. Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility. Ann Surg Oncol 26(9):2667-2674, 2019. e-Pub 2019. PMID: 31168736.
      50. Fry BT, Scally CP, Thumma JR, Dimick JB. Quality Improvement in Bariatric Surgery: The Impact of Reducing Postoperative Complications on Medicare Payments. Ann Surg 268(1):22-27, 2018. e-Pub 2018. PMID: 29206678.
      51. Sandhu G, Magas CP, Robinson AB, Scally CP, Minter RM. Progressive Entrustment to Achieve Resident Autonomy in the Operating Room: A National Qualitative Study With General Surgery Faculty and Residents. Ann Surg 265(6):1134-1140, 2017. e-Pub 2017. PMID: 27163961.
      52. Pradarelli JC, Scally CP, Nathan H, Thumma JR, Dimick JB. Hospital Teaching Status and Medicare Expenditures for Complex Surgery. Ann Surg 265(3):502-513, 2017. e-Pub 2017. PMID: 28169925.
      53. Scally CP, Varban OA, Carlin AM, Birkmeyer JD, Dimick JB, Surgery Collaborative MB. Video Ratings of Surgical Skill and Late Outcomes of Bariatric Surgery. JAMA Surg 151(6):e160428, 2016. e-Pub 2016. PMID: 27074114.
      54. Krell RW, Scally CP, Wong SL, Abdelsattar ZM, Birkmeyer NJ, Fegan K, Todd J, Henke PK, Campbell DA, Hendren S. Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery. Ann Surg Oncol 23(5):1431-9, 2016. e-Pub 2016. PMID: 26567148.
      55. Reames BN, Scally CP, Frankel TL, Dimick JB, Nathan H. National trends in resection of cystic lesions of the pancreas. HPB (Oxford) 18(4):375-82, 2016. e-Pub 2016. PMID: 27037208.
      56. Scally CP, Shih T, Thumma JR, Dimick JB. Impact of a National Bariatric Surgery Center of Excellence Program on Medicare Expenditures. J Gastrointest Surg 20(4):708-14, 2016. e-Pub 2016. PMID: 26582598.
      57. Scally CP, Yin H, Birkmeyer JD, Wong SL. Comparing perioperative processes of care in high and low mortality centers performing pancreatic surgery. J Surg Oncol 112(8):866-71, 2015. e-Pub 2015. PMID: 26593455.
      58. Scally CP, Ryan AM, Thumma JR, Gauger PG, Dimick JB. Early impact of the 2011 ACGME duty hour regulations on surgical outcomes. Surgery 158(6):1453-61, 2015. e-Pub 2015. PMID: 26054323.
      59. Alameddine MB, Claflin J, Scally CP, Noble DM, Reames BN, Englesbe MJ, Wong SL. Resident Surgeons Underrate Their Laparoscopic Skills and Comfort Level When Compared With the Rating by Attending Surgeons. J Surg Educ 72(6):1240-6, 2015. e-Pub 2015. PMID: 26395401.
      60. Scally CP, Sandhu G, Magas C, Gauger PG, Minter RM. Investigating the Impact of the 2011 ACGME Resident Duty Hour Regulations on Surgical Residency Programs: The Program Director Perspective. J Am Coll Surg 221(4):883-9.e1, 2015. e-Pub 2015. PMID: 26272015.
      61. Scally CP, Thumma JR, Birkmeyer JD, Dimick JB. Impact of Surgical Quality Improvement on Payments in Medicare Patients. Ann Surg 262(2):249-52, 2015. e-Pub 2015. PMID: 25493360.
      62. Reames BN, Scally CP, Thumma JR, Dimick JB. Evaluation of the Effectiveness of a Surgical Checklist in Medicare Patients. Med Care 53(1):87-94, 2015. e-Pub 2015. PMID: 25464163.
      63. Scally CP, Reames BN, Teman NR, Fritze DM, Minter RM, Gauger PG. Preserving operative volume in the setting of the 2011 ACGME duty hour regulations. J Surg Educ 71(4):580-6, 2014. e-Pub 2014. PMID: 24969673.

      Review Articles

      1. Malik, N, Krause, KJ, Keung, EZ, Lyu, H, Lillemoe, HA, Scally, CP, Torres, KE, Hunt, KK, Austin, M, Roland, CL. Optimal surveillance for detecting sarcoma lung metastasis – A systematic review. Surgical Oncology Insight 2(1), 2025. e-Pub 2025. PMID: 40191537.
      2. Fanaeian, M, Yousef, M, Yousef, A, Foo, WC, Taggart, MW, Beaty, K, Scally, CP, Mansfield, PF, Fournier, KF, Helmink, BA, Shen, JY. Risk of relapse after surgical resection of localized appendiceal adenocarcinoma. Journal of Clinical Oncology 42:58, 2024. e-Pub 2024.
      3. Scally CP, Minter RM. Medical School Training for the Surgeon. Surg Clin North Am 96(1):1-13, 2016. e-Pub 2016. PMID: 26612015.
      4. Scally CP, Gauger PG, Dimick JB. The Institute of Medicine Report on Graduate Medical Education Funding: Implications for Surgical Training. JAMA Surg 150(6):501-2, 2015. e-Pub 2015. PMID: 25830348.
      5. Scally CP, Wong SL. Intensity of follow-up after melanoma surgery. Ann Surg Oncol 21(3):752-7, 2014. e-Pub 2014. PMID: 24114053.

      Editorials

      1. Lyu, H, Roland, CL, Scally, CP. ASO Author Reflections: The Optimal Timing for Resection in Patients with Small GISTs: Balancing Risks and Benefits. Annals of surgical oncology 31(13):9285-9286, 2024. PMID: 39320401.
      2. White MG, Scally CP. ASO Author Reflections: Contemporary Management of Low-Grade Appendiceal Mucinous Neoplasms. Ann Surg Oncol 30(13):8168-8169, 2023. PMID: 37231292.
      3. Traweek RS, Roland CL, Scally CP. ASO Author Reflections: Management of Patients with Soft Tissue Sarcoma Following Unplanned Excision. Ann Surg Oncol 30(1):490-491, 2023. PMID: 36076129.

      Abstracts

      1. Seldomridge, AN, White, MG, Scally, CP, Royal, RE, Routbort, MJ, Iorgulescu, JB, Overman, MJ, Lee, SM, Foo, WC, Taggart, MW, Song, Y, Mansfield, PF, Fournier, KF, Shen, JY, Helmink, BA. ASO Visual Abstract. Annals of surgical oncology 33(3):2439-2440, 2026. e-Pub 2026. PMID: 41366166.
      2. Fallon, EA, Awiwi, M, Bhutiani, N, Helmink, BA, Scally, CP, Mansfield, PF, Fournier, KF, Vikram, R, Uppal, A, White, MG. ASO Visual Abstract: Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis. Annals of surgical oncology 32(4):2942, 2025. e-Pub 2025. PMID: 39847285.
      3. Traweek RS, Lyu H, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. ASO Visual Abstract: High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival Following Resection of Extremity and Truncal Soft-Tissue Sarcoma. Ann Surg Oncol 31(6):4150-4151, 2024. e-Pub 2024. PMID: 38546800.
      4. White MG, Bhutiani N, Helmink BA, Taggart M, Foo WC, Mansfield PF, Fournier KF, Scally CP. ASO Visual Abstract: Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol 30(13):8176, 2023. e-Pub 2023. PMID: 37728822.
      5. Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB. ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Ann Surg Oncol 30(13):8178-8179, 2023. e-Pub 2023. PMID: 37768415.
      6. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership. Ann Surg Oncol 30(6):3679-3680, 2023. e-Pub 2023. PMID: 36826618.
      7. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):941-942, 2023. e-Pub 2023. PMID: 36161369.
      8. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):492, 2023. e-Pub 2023. PMID: 36245056.
      9. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. ASO Visual Abstract: Sentinel Lymph Node Biopsy and Formal Lymphadenectomy For Soft Tissue Sarcoma: A Single-Center Experience of 86 Consecutive Cases. Ann Surg Oncol. e-Pub 2022. PMID: 35644862.
      10. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. ASO Visual Abstract: Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. e-Pub 2022. PMID: 35254579.
      11. Scally CP, Robinson KA, Beaty K, Rafeeq S, Raghav K, Eng C, Overman M, Foo WC, Taggart MW, Mansfield P, Royal RE, Fournier KF. Low-Grade Appendiceal Mucinous Neoplasms: Treatment Variation and Long-Term Outcomes, 2020. e-Pub 2020.
      12. Scally CP, Rodriguez-Bigas M, Nguyen ST, Chang G, Bednarski BK, Messick CA, Lynch PM, VilarSanchez E, You YN. The Evolving Application of Panel-Based Tests for Defining Hereditary Colorectal Cancer Susceptibility, 2018. e-Pub 2018.
      13. Scally CP, Ryan A, Gauger PG, Dimick JB. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients, 2015. e-Pub 2015.
      14. Scally CP, Sandhu G, Magas C, Gauger PG, Minter RM. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees, 2015. e-Pub 2015.
      15. Sandhu G, Scally CP, Magas C, Gauger PG, Minter RM. Resident-Attending Interactions and Progressive Autonomy in the Operating Room, 2015. e-Pub 2015.
      16. Scally CP, Sandhu G, Magas C, Gauger PG, Minter RM. Investigating the Impact of the 2011 ACGME Duty Hour Restrictions on Surgical Trainees, 2015. e-Pub 2015.
      17. Reames BR, Scally CP, Frankel TL, Dimick JB, Nathan H. National Trends in Resection of Cystic Lesions of the Pancreas, 2015. e-Pub 2015.
      18. Scally CP, Yin H, Birkmeyer JD, Wong SL. Comparing Perioperative Processes of Care in High and Low Mortality Centers Performing Pancreatic Surgery, 2015. e-Pub 2015.
      19. Scally CP, Warner S, Minter RM. Incorporating Transition to Practice into a HPB Fellowship: A model for Graduated Autonomy, 2015. e-Pub 2015.
      20. Hill HL, Grenda TR, Thumma JR, Dimick JB, Scally CP. Hospital Competition and Adoption of New Procedures in Low Volume Settings, 2015. e-Pub 2015.
      21. Scally CP, Ryan A, Gauger PG, Dimick JB. Preliminary Impact of the 2011 ACGME Duty Hour Requirements on Surgical Patients, 2015. e-Pub 2015.
      22. Scally CP, Birkmeyer JD, Dimick JB. Impact of Surgical Quality Improvement on Costs in Medicare Patients, 2014. e-Pub 2014.

      Book Chapters

      1. Scally CP, Roland CL. Efficient, Comprehensive Patient Care for Multidisciplinary Visits. In: Healthcare Delivery in Surgery: Scientific Principles and Practice. Lipincott Wolters Kluwer, 2023.
      2. Scally, CP, Suwanabol, PA. What Interventions Are Effective for Relieving Acute Bowel Obstruction in Cancer and Other Conditions?. In: Evidence-Based Practice of Palliative Medicine. Elsevier, 171-178, 2023.
      3. Harbaugh CM, Scally CP, Hinshaw DB, Suwanabol PA. Between a Rock and a Hard Place: Anticipating Poor Surgical Outcomes While Honoring Patient Autonomy. In: Palliative Skills for Frontline Clinicians. Springer Nature, 145-152, 2020.
      4. Scally CP, Doherty GM. Evaluation of a Neck Mass. In: ACS Surgery: Principles & Practice. Decker Intellectual Properties, 2012.
      5. Fallon EA, Scally CP. Right Hemicolectomy for Appendiceal Mucinous Neoplasms. In: Difficult Decisions in Surgical Oncology: An Evidence-Based Approach. Springer Nature.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 08, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top